4/4
08:03 am
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
4/1
04:48 pm
tngx
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/20
08:08 am
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target raised by analysts at HC Wainwright from $16.00 to $17.00. They now have a "buy" rating on the stock.
Medium
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target raised by analysts at HC Wainwright from $16.00 to $17.00. They now have a "buy" rating on the stock.
3/18
06:35 pm
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Medium
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
3/18
07:09 am
tngx
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights [Yahoo! Finance]
Medium
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights [Yahoo! Finance]
3/18
07:00 am
tngx
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
Medium
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
3/6
07:12 am
tngx
Tango Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Tango Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/6
07:00 am
tngx
Tango Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Tango Therapeutics to Participate in Upcoming Investor Conferences
3/5
04:53 pm
tngx
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
Low
Report
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
3/5
04:47 pm
tngx
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
Low
Report
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
3/4
08:09 am
tngx
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer [Yahoo! Finance]
Low
Report
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer [Yahoo! Finance]
3/3
07:25 am
tngx
Companies Like Tango Therapeutics (NASDAQ:TNGX) Are In A Position To Invest In Growth [Yahoo! Finance]
Low
Report
Companies Like Tango Therapeutics (NASDAQ:TNGX) Are In A Position To Invest In Growth [Yahoo! Finance]
2/12
07:07 am
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $18.00 price target on the stock.
Low
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $18.00 price target on the stock.
1/31
07:12 am
tngx
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference [Yahoo! Finance]
Low
Report
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference [Yahoo! Finance]
1/31
07:00 am
tngx
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
Low
Report
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference